Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation

被引：34
|
作者：
Potpara, Tatjana S. [1 ,2 ]
Lip, Gregory Y. H. [1 ,3 ]
机构：
[1] Univ Belgrade, Sch Med, Belgrade, Serbia
[2] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia
[3] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 317卷 / 11期
关键词：
DABIGATRAN; RIVAROXABAN; WARFARIN; SAFETY; METAANALYSIS; COHORT; RISK;
D O I：
10.1001/jama.2017.1152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1115 / 1116
页数：2
相关论文
共 50 条
  • [1] Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Plitt, Anna
    Ruff, Christian T.
    Giugliano, Robert P.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1019 - +
  • [2] Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation
    Basaran, Ozcan
    Dogan, Volkan
    Sahin, Cem
    Biteker, Murat
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 357 - 357
  • [3] Non-Vitamin K Antagonist Oral Anticoagulants in the Treatment of Atrial Fibrillation
    Fanaroff, Alexander C.
    Ohman, E. Magnus
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 61 - 75
  • [4] How safe are non-vitamin K antagonist oral anticoagulants in atrial fibrillation?
    De Caterina, Raffaele
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0I) : 1 - 6
  • [5] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia
    Janion-Sadowska, Agnieszka
    Papuga-Szela, Elbieta
    Lukaszuk, Robert
    Chrapek, Magdalena
    Undas, Anetta
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (03) : 153 - 160
  • [6] Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
    Undas, Anetta
    Drabik, Leszek
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (01): : 10 - 18
  • [7] Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Middeldorp, Melissa E.
    Gupta, Aashray
    Elliott, Adrian
    Kadhim, Kadhim
    Thiyagarajah, Anand
    Gallagher, Celine
    Hendriks, Jeroen
    Linz, Dominik
    Emami, Mehrdad
    Mahajan, Rajiv
    Lau, Dennis
    Sanders, Prashanthan
    [J]. HEART, 2021, 107 (12) : 971 - 976
  • [8] Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
    Giugliano, Robert P.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A1 - A10
  • [9] The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
    Patti, Giuseppe
    Cavallari, Ilaria
    Hanon, Olivier
    De Caterina, Raffaele
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 118 - 124
  • [10] Reply to "Non-vitamin K antagonist oral anticoagulants for atrial fibrillation in obese patients"
    Gupta, Rajeev
    Desai, Rupak
    Gupta, Neelesh
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2020, 130 : 167 - 168
12345